A clinical trial to test a new cancer drug in patients with advanced solid tumours, launches in four centres across the UK today (Wednesday), through Cancer Research UK’s Centre for Drug Development.
We strive at APHA Scientific to offer you the best value to our customers. Which is why we have reduced the cost of our Avian Reagents, by 30%.
Peter Cousins APHA Scientifics Business Development Manager said:
“It is great news that we are able to pass on savings to make it even more affordable for customers. So, I’m thrilled to announce that we have lowered the price of our Avian Reagents.
“We are committed to giving our customers better value for money and APHA Scientific believes that it is important to reflect this in the prices.”
Cancer Research UK and Newcastle University have recently announced a three year extension to their major strategic drug discovery alliance with Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics.
An experimental immuno-oncology treatment will move into early phase clinical trials for patients with advanced solid tumours, including lung cancers, under a collaboration agreement between Cancer Research UK and Biotecnol Limited.
In late 2016, HEFCE invited long-term strategies from higher education institutions (HEIs) in receipt of a 2016-17 Higher Education Innovation Fund allocation to submit five-year knowledge exchange (KE) strategies, as the basis for release of future allocations. HEFCE commissioned researchers RSM PACEC to assess and provide advice to HEFCE on the strategies, and to produce an overview report.
The NIHR Brain Injury Healthcare Technology Co-operative (HTC) will hold its third focused Brain Injury Technologies Think (BITT) tank on ‘Paediatric Neurorehabilitation’ on Tuesday 17th October 2017 in London (venue to be confirmed).
This networking event provides an opportunity for tech innovators to showcase novel solutions and for the expert clinicians, industry partners and academics, etc to offer independent feedback, as well as to explore the potential for collaboration.
Open and collaborative scientific research is vital to the discovery and translation of new knowledge into products and services that benefit society. Many research institutions, funding bodies, policy makers and journals recognize the benefits of open research practices – from minimizing the duplication of efforts and improving research reproducibility to facilitating collaborations and combating scientific fraud.
University-business collaboration has been given a boost this week with the announcements by HEFCE of a HEIF 'uplift' for English universities and awards of £177 million through the UK Research Investment Partnership Fund (UKRIPF).
The announcement that Statoil, Vattenfall and Gasunie have signed a Memorandum of Understanding to evaluate the possibilities of converting Vattenfall’s gas
This feature presents some of the most disruptive innovations published in the second quarter of 2017, by universities actively looking to find external collaboration partners through IN-PART. From monitoring plastic pollution in the oceans, to relieving pain in virtual reality, and inducing rainfall with lasers, the creativity of scientific research is inspiring.